Excelliance MOS Corporation (TPEX:5299)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.80
+0.10 (0.15%)
Aug 12, 2025, 1:30 PM CST

Ligand Pharmaceuticals Revenue

Excelliance MOS had revenue of 406.22M TWD in the quarter ending June 30, 2025, a decrease of -7.75%. This brings the company's revenue in the last twelve months to 1.66B, down -4.61% year-over-year. In the year 2024, Excelliance MOS had annual revenue of 1.69B, down -2.38%.

Revenue (ttm)
1.66B
Revenue Growth
-4.61%
P/S Ratio
2.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.69B-41.23M-2.38%
Dec 31, 20231.73B-601.36M-25.76%
Dec 31, 20222.33B-422.29M-15.32%
Dec 31, 20212.76B802.86M41.09%
Dec 31, 20201.95B305.76M18.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition